First Time Loading...

Well Lead Medical Co Ltd
SSE:603309

Watchlist Manager
Well Lead Medical Co Ltd Logo
Well Lead Medical Co Ltd
SSE:603309
Watchlist
Price: 12.68 CNY -0.24% Market Closed
Updated: May 15, 2024

Cash Flow Statement

Cash Flow Statement
Well Lead Medical Co Ltd

Rotate your device to view
Cash Flow Statement
Currency: CNY
Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Operating Cash Flow
Cash Taxes Paid
(15)
(17)
(14)
(14)
(15)
(17)
(17)
(13)
(14)
(16)
(21)
(23)
(22)
(25)
(19)
(21)
(18)
(23)
(32)
(44)
(51)
(54)
(61)
(63)
(66)
(61)
(52)
(41)
(46)
(45)
(38)
(37)
(51)
(70)
(76)
(82)
(44)
(35)
Change in Working Capital
(162)
(157)
(181)
(173)
(195)
(201)
(203)
(198)
(198)
(206)
(213)
(227)
(245)
(262)
(266)
(291)
(307)
(333)
(364)
(362)
(352)
(343)
(340)
(370)
(362)
(383)
(395)
(391)
(416)
(436)
(446)
(459)
(461)
(463)
(467)
(445)
(460)
(464)
Cash from Operating Activities
107
N/A
111
+3%
75
-32%
81
+7%
82
+1%
78
-4%
91
+16%
80
-12%
85
+7%
71
-17%
79
+11%
78
0%
74
-5%
64
-13%
82
+28%
72
-12%
90
+24%
114
+27%
119
+4%
171
+45%
179
+4%
185
+3%
218
+18%
224
+3%
228
+2%
214
-6%
200
-6%
173
-14%
187
+8%
213
+14%
280
+31%
354
+26%
391
+11%
431
+10%
298
-31%
239
-20%
223
-7%
193
-13%
Investing Cash Flow
Capital Expenditures
(52)
(44)
(37)
(43)
(37)
(55)
(63)
(59)
(69)
(64)
(57)
(58)
(71)
(65)
(75)
(82)
(79)
(83)
(87)
(96)
(113)
(108)
(112)
(104)
(93)
(106)
(103)
(117)
(109)
(126)
(136)
(142)
(181)
(206)
(230)
(319)
(358)
(365)
Other Items
(3)
(303)
(247)
(304)
(317)
111
(15)
(11)
(13)
(112)
11
82
49
6
(49)
(101)
(236)
(219)
(249)
(224)
21
18
54
59
(3)
(35)
(12)
(36)
(47)
(325)
(519)
(478)
(379)
(188)
95
183
33
85
Cash from Investing Activities
(54)
N/A
(347)
-541%
(284)
+18%
(346)
-22%
(354)
-2%
57
N/A
(78)
N/A
(69)
+11%
(82)
-19%
(175)
-113%
(46)
+74%
24
N/A
(22)
N/A
(59)
-164%
(124)
-109%
(183)
-48%
(315)
-72%
(303)
+4%
(335)
-11%
(320)
+5%
(92)
+71%
(90)
+2%
(58)
+36%
(45)
+22%
(96)
-112%
(141)
-47%
(115)
+18%
(153)
-33%
(156)
-2%
(451)
-188%
(655)
-45%
(621)
+5%
(560)
+10%
(394)
+30%
(134)
+66%
(136)
-1%
(324)
-138%
(280)
+14%
Financing Cash Flow
Net Issuance of Debt
(20)
(59)
(82)
(40)
(45)
0
0
0
0
0
0
0
0
0
38
50
258
238
216
204
(33)
0
(58)
(58)
(91)
0
(13)
10
65
126
39
(3)
21
8
(28)
79
133
363
Cash Paid for Dividends
(14)
(3)
(2)
(25)
(31)
0
0
0
0
0
(25)
(30)
(30)
(30)
(35)
(31)
(33)
(36)
(30)
(33)
(34)
(34)
(53)
(52)
(51)
(51)
(68)
(68)
(59)
(65)
(48)
(48)
(45)
(46)
(76)
(105)
(107)
(108)
Other
0
347
352
352
352
0
0
2
6
6
11
9
7
11
12
15
14
15
7
5
2
0
0
(3)
4
6
6
4
408
413
402
401
(23)
(24)
(29)
(30)
(14)
(14)
Cash from Financing Activities
(34)
N/A
285
N/A
268
-6%
288
+7%
276
-4%
0
N/A
(30)
N/A
(6)
+81%
6
N/A
6
N/A
(14)
N/A
(21)
-54%
(24)
-11%
(20)
+17%
15
N/A
35
+137%
238
+585%
216
-9%
193
-11%
176
-9%
(64)
N/A
(49)
+23%
(112)
-127%
(112)
N/A
(138)
-23%
(136)
+1%
(76)
+45%
(54)
+28%
414
N/A
473
+14%
393
-17%
350
-11%
(47)
N/A
(62)
-32%
(134)
-116%
(56)
+58%
12
N/A
241
+1 967%
Change in Cash
Effect of Foreign Exchange Rates
(0)
(0)
(0)
2
3
3
5
2
4
4
1
(1)
(5)
(8)
(5)
(1)
1
3
2
1
(1)
1
0
(2)
(4)
(4)
(5)
(4)
(2)
(2)
1
2
3
3
3
1
2
2
Net Change in Cash
19
N/A
49
+163%
59
+19%
25
-58%
7
-72%
113
+1 554%
(12)
N/A
7
N/A
13
+86%
(94)
N/A
20
N/A
80
+292%
23
-71%
(22)
N/A
(32)
-43%
(77)
-144%
15
N/A
31
+112%
(23)
N/A
28
N/A
22
-20%
45
+105%
49
+8%
65
+33%
(9)
N/A
(67)
-628%
5
N/A
(38)
N/A
443
N/A
233
-47%
19
-92%
85
+345%
(213)
N/A
(23)
+89%
32
N/A
48
+49%
(89)
N/A
157
N/A
Free Cash Flow
Free Cash Flow
56
N/A
67
+20%
39
-42%
38
-1%
45
+17%
24
-47%
28
+19%
21
-24%
16
-23%
8
-54%
22
+192%
20
-9%
3
-84%
(0)
N/A
7
N/A
(10)
N/A
11
N/A
31
+174%
32
+3%
75
+137%
66
-12%
76
+15%
106
+39%
121
+13%
136
+13%
108
-20%
97
-10%
56
-43%
78
+39%
87
+12%
144
+65%
212
+47%
210
-1%
225
+7%
68
-70%
(80)
N/A
(135)
-70%
(172)
-27%

See Also

Discover More